Home › Funds › D. E. Shaw & Co › CELC
D. E. Shaw & Co position in CELC
CELCUITY INC · Health Care
Latest position (Q2 2026)30.39K sh
Reported value held$3.18M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 18.86K | $339.00K | New |
| Q4 2021 | 16.16K | $213.00K | Reduce |
| Q1 2022 | 18.74K | $175.00K | Add |
| Q2 2022 | 13.20K | $120.00K | Reduce |
| Q3 2025 | 11.25M | $15.00M | New |
| Q4 2025 | 57.65K | $5.75M | Reduce |
| Q1 2026 | 20.72K | $2.36M | Reduce |
| Q2 2026 | 30.39K | $3.18M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CELC
- Vanguard Group 2.28M sh · $227.35M · Q4 2025
- Bank of America Corp 1.47M sh · $153.93M · Q2 2026
- Geode Capital Management 1.11M sh · $116.33M · Q2 2026
- Wellington Management Group 906.60K sh · $94.85M · Q2 2026
- Point72 Asset Management 650.92K sh · $68.10M · Q2 2026
- UBS Group AG 520.95K sh · $54.50M · Q2 2026
- Northern Trust Corp 356.92K sh · $37.34M · Q2 2026
- Charles Schwab Investment Management 320.89K sh · $33.57M · Q2 2026
- Citadel Advisors 18.00M sh · $20.50M · Q2 2026
- Marshall Wace 182.16K sh · $19.06M · Q2 2026
- BlackRock Inc 12.97M sh · $14.74M · Q2 2026
- BNY Mellon 116.37K sh · $12.17M · Q2 2026